CN104721564A - Externally applied agent for treating residual burn wounds - Google Patents
Externally applied agent for treating residual burn wounds Download PDFInfo
- Publication number
- CN104721564A CN104721564A CN201510120643.4A CN201510120643A CN104721564A CN 104721564 A CN104721564 A CN 104721564A CN 201510120643 A CN201510120643 A CN 201510120643A CN 104721564 A CN104721564 A CN 104721564A
- Authority
- CN
- China
- Prior art keywords
- parts
- effects
- externally applied
- applied agent
- burn wounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention relates to an externally applied agent for treating residual burn wounds. The externally applied agent is prepared from the following medicinal materials in parts by weight: 6 parts of bletilla, 9 parts of caulis sinomenii, 8 parts of artemisia stelleriana, 9 parts of white paeony root, 6 parts of beeweed and 2 parts of centipede. The application of the externally applied agent is as follows: the bletilla has the effects of astringing to arrest bleeding, dispelling edema and promoting granulation; the caulis sinomenii has the effects of dispelling wind and arresting itching, activating blood circulation and detoxicating; the artemisia stelleriana has the effects of cooling blood and hemostasis; the white paeony root has the effects of stopping pain, astringency and nourishing blood; the centipede has the effects of draining pus and dispelling edema; the beeweed has the effects of resolving toxin and disperse swelling; the medicines are combined used with the functions of alleviating pain and relieving itching, detoxifying and draining pus, activating blood and promoting granulation, astringing trauma, and effectively promoting the recovery of the residual burn wounds.
Description
Technical field
The present invention relates to a kind of medicine for external use being used for the treatment of residual burn wound.
Background technology
Deep burn wound can not heal in a short time, or because infect the burn not having primary healing, needs the wound surface of the Comprehensive Treatments such as debridement, infection, skin-grafting, be called residual burn wound.Residual burn wound is very common clinically, multiple be born in various depth of burn later stage or new epithelize very fragile, not rub resistance, and form the multiple wound surface that is dispersed in, or form little wound surface after functional exercise generation blister ulceration, though this wound surface is through various measure process, still prolongedly not heal, time serious, even seriously jeopardize patient vitals.
The origin cause of formation of residual wound mainly contains: 1. skin graft is not enough, and after extensive deep burn, autologous skin source is limited, and self-skin transplant density because other reasons skin graft does not survive, causes skin graft to fail to spread flap coverage not or after skin-grafting.2. refractory infection, because the course of disease is long, antibiotic application causes the appearance of wound surface antibacterial severe infections and Resistant strain repeatedly, current methicillin resistant staphylococcus aureus, Meticillin Coagulase Negative Staphylococcus, pseudomonas aeruginosa, Acinetobacter bauamnnii, infect the trend all having rising.Antibacterial and metabolite thereof hinder and suppress the growth of epithelium.3. new epithelize is not wear-resisting, and new epithelize is thin, not abrasion-resistant, easily forms little wound surface.3. blood fortune in local is poor, and long-term bed does not get enough athletic exercise, and amyotrophy can cause venous return obstacle, or after cicatrization, local blood fortune is also poor.The position wound surface of blood fortune difference is prolonged does not heal.5. wound surface local factor, forms a scab after the secretions inadequate drainage of wound surface remaining sebaceous gland, sweat gland etc. forms abscess ulceration or Wound treatment, but under crust, inadequate drainage causes subinfection again and causes wound surface and fester and prolongedly not heal.6. the impact of systemic factor, the long-term wound surface of patient oozes out and causes malnutrition, immunity degradation, trace element deficiency or when being associated with the wasting diseases such as diabetes, tuberculosis, all can cause that wound surface is prolonged does not heal.
Summary of the invention
The present invention aims to provide a kind of medicine for external use being used for the treatment of residual burn wound, by selecting suitable Chinese crude drug and proportioning thereof, reaches the object that safe and effective promotion residual burn wound recovers.
In order to achieve the above object, the present invention is by the following technical solutions:
Be used for the treatment of a medicine for external use for residual burn wound, it is characterized in that, it is prepared from by the medical material of following weight proportion: the Pseudobulbus Bletillae (Rhizoma Bletillae) 6 parts, Caulis Sinomenii 9 parts, Herba Artemisiae Sieversianae 8 parts, the Radix Paeoniae Alba 9 parts, Chinese mugwort in thousand 6 parts, Scolopendra 2 parts.
The present invention uses: Pseudobulbus Bletillae (Rhizoma Bletillae) astringing to arrest bleeding, detumescence and promoting granulation; Caulis Sinomenii dispelling wind for relieving itching, promoting blood circulation and detoxication; Herba Artemisiae Sieversianae cooling blood for hemostasis; Radix Paeoniae Alba pain relieving, convergence, nourishes blood; Scolopendra is drawn out the pus detumescence; Chinese mugwort removing toxic substances and promoting subsidence of swelling in thousand; All medicines share, and it is antipruritic to play analgesia altogether, and removing toxic substances is drawn out the pus, blood activating and promoting tissue regeneration, and effect of convergence wound, effectively promotes the recovery of residual burn wound.
Below in conjunction with experimental data, beneficial effect of the present invention is described:
1, physical data
Applicant collects patient 40 example altogether, wherein man 21 example, female 19 example.Age reckling 16 years old, maximum 67 years old.Wherein electric burn 4 example, 22 examples scalded by boiled water, flame burn 9 example, electric arc burn 5 example.Residual wound position: chest and back 10 example, upper limb 7 example, lower limb 15 example, extremity have 8 examples entirely.Maximum area 15cm × 18cm, minimum area 1 cm × 2cm.Before treatment, wound surface festers repeatedly, the longest 90 d, the shortest 20 d.
Inclusive criteria: 1. 16 ~ 68 years old age; 2. this experimental therapy is accepted voluntarily.
Exclusion standard: 1. radiation burn patient; 2. the heart, brain, liver, IIR, disease of hematopoietic system and psychotic is merged; 3. anemia of pregnant woman, women breast-feeding their children and allergic constitution person.
2, test method
All patients first with 1:1000 bromo geramine cleaning wound surface, wash away dirt and crust, after clean with normal saline flushing, in the powder that wound surface external application the present invention obtains according to specific embodiment 1, then use sterile gauze external application wrapping, changing dressings every day once, 2 weeks is a course for the treatment of.Curative effect is added up after the course for the treatment of.
3, criterion of therapeutical effect and therapeutic outcome
3.1 curative effect judging standard
Invalid, residual wound healing area <40% or wound surface is unchanged after changing dressings even worsens;
Effectively, residual wound healing area 40% ~ 90%;
Effective, residual wound healing area >90%.
3.2 treatment statistical results are in table 1.
Table 1 liang group comparitive study
| n | Effective | Effectively | Invalid | Untoward reaction example | Total effective rate (%) |
| 40 | 30 | 8 | 2 | 0 | 95% |
Visible, the medicine that the present invention obtains can the safe and effective treatment for residual burn wound.
Detailed description of the invention
In order to understand better and implement the present invention, further illustrate the present invention below in conjunction with specific embodiment.
Embodiment 1
Take: the Pseudobulbus Bletillae (Rhizoma Bletillae) 6 parts, Caulis Sinomenii 9 parts, Herba Artemisiae Sieversianae 8 parts, the Radix Paeoniae Alba 9 parts, Chinese mugwort in thousand 6 parts, Scolopendra 2 parts; Add 8 times of water gagings, decoct 1.5 hours, filter; Filtering residue adds 6 times of water gagings, decocts 1 hour, filters; Merging filtrate, concentrated, dry, pulverize into fine powder, obtain powder of the present invention.Above-mentioned part all refers to weight portion.
For the treatment of residual burn wound.External, gets and is coated on affected part in right amount, and then use sterile gauze external application wrapping, changing dressings every day once, 2 weeks is a course for the treatment of.
Claims (1)
1. be used for the treatment of a medicine for external use for residual burn wound, it is characterized in that, it is prepared from by the medical material of following weight proportion: the Pseudobulbus Bletillae (Rhizoma Bletillae) 6 parts, Caulis Sinomenii 9 parts, Herba Artemisiae Sieversianae 8 parts, the Radix Paeoniae Alba 9 parts, Chinese mugwort in thousand 6 parts, Scolopendra 2 parts.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510120643.4A CN104721564A (en) | 2015-03-19 | 2015-03-19 | Externally applied agent for treating residual burn wounds |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510120643.4A CN104721564A (en) | 2015-03-19 | 2015-03-19 | Externally applied agent for treating residual burn wounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104721564A true CN104721564A (en) | 2015-06-24 |
Family
ID=53446360
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510120643.4A Pending CN104721564A (en) | 2015-03-19 | 2015-03-19 | Externally applied agent for treating residual burn wounds |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104721564A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107158233A (en) * | 2017-05-11 | 2017-09-15 | 王亮 | A kind of externally applied drug for being used to treat burn wound |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1623595A (en) * | 2003-12-02 | 2005-06-08 | 陈凯 | Ointment for curing burn and scald |
| KR20140097095A (en) * | 2014-07-22 | 2014-08-06 | (주)아모레퍼시픽 | Composition for promoting the volume of skin |
-
2015
- 2015-03-19 CN CN201510120643.4A patent/CN104721564A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1623595A (en) * | 2003-12-02 | 2005-06-08 | 陈凯 | Ointment for curing burn and scald |
| KR20140097095A (en) * | 2014-07-22 | 2014-08-06 | (주)아모레퍼시픽 | Composition for promoting the volume of skin |
Non-Patent Citations (2)
| Title |
|---|
| 彭成等: "《中药药理学》", 31 December 2014 * |
| 江培良: "《实用本草药性歌括》", 31 January 2007 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107158233A (en) * | 2017-05-11 | 2017-09-15 | 王亮 | A kind of externally applied drug for being used to treat burn wound |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101167847B (en) | Traditional Chinese medicinal white spirit preparation for effectively treating skin disease | |
| JP6681482B2 (en) | Topical pharmaceutical composition for the treatment of various wound wounds on the skin and method for preparing the same | |
| CN103230493B (en) | Traditional Chinese medicine composition for treating unhealed wound | |
| CN103623104B (en) | A kind ofly treat Chinese medicine patch of skin superficial position inflammation and preparation method thereof | |
| CN102824449B (en) | A kind of external-use tincture for the treatment of decubital ulcer, traumatic infection, diabetic dermopathy | |
| CN102228623B (en) | Medicinal composition for treating burn and scald and preparation method thereof | |
| CN104721564A (en) | Externally applied agent for treating residual burn wounds | |
| CN101401890B (en) | External use medicament capable of effectively treating wound surface infection | |
| CN114886967A (en) | External traditional Chinese medicine composition for promoting tissue regeneration and preparation method thereof | |
| CN109646512B (en) | A topical Chinese medicinal composition for promoting healing of chronic intractable wound | |
| CN101028365B (en) | Medicine for treating burn and ambustion and its production | |
| CN103705678A (en) | Traditional Chinese medicinal oil for treating bedsores | |
| CN107158233A (en) | A kind of externally applied drug for being used to treat burn wound | |
| CN102813828B (en) | Stropanthus divericatus for treating external wounds | |
| CN103655756B (en) | The Chinese medicine for outer use for the treatment of cutization pyogenic infection | |
| CN105832909A (en) | Traditional Chinese medicine preparation for treating necrotic ulcer of skin | |
| Sathish et al. | Sushruta’s eight pearls for Infective Ulcer | |
| CN103638173B (en) | The Chinese medicine for outer use for the treatment of decubital ulcer | |
| JP5551459B2 (en) | Method for increasing medicinal effect of external preparation for skin or antibacterial preparation for trauma inflammation | |
| CN104398992A (en) | Traditional Chinese medicinal preparation for treating infectious trauma | |
| CN105079404A (en) | External traditional Chinese medicinal lotion for treating infective wound caused by multi-drug resistant bacteria | |
| CN105560343A (en) | Traditional Chinese medicine composition for treating neonatal omphalitis | |
| CN1137707C (en) | Skin rehabilitation medicine for treating burn and scald | |
| CN104027404A (en) | Traditional Chinese medicine washing liquor used for treating leukoplakia vulvae | |
| CN103083373B (en) | Specific medicine for treating burns and scalds and other skin injury |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20150624 |